FDA Investigator Victor J Gangi

Victor J Gangi has inspections in 6 countries as of 13 Oct 2023. Victor J Gangi has collaborated with a combinined 2087 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:
19
Last Inspection Date:
13 Oct 2023
Investigator Role:
FDA Investigation Participant
Redica ID:
100006970
Country:
United States of America, Spain, United Kingdom of Great Britain and Northern Ireland, Germany, France, Italy
Co-Investigator(s):
Aimee Cunningham, PhD, Amber G Wardwell, Amy C Jordan, Amy Devlin, PhD, Andrew M Barlow, Anissa M Cheung, Arie C Menachem, Ariel Cruz Figueroa, Brenda P King, Brentley S Collins, Brently S Collins, Burnell M Henry, Camerson E Moore, Carl A Huffman, III, Carla C Tuite, CDR Thomas R Berry, PPh, Charles A Snipes, PhD, Charles R Bonapace, PhD, Christian D Lynch (CDL), Christina Capacci Daniel, PhD, Christopher Downey, PhD, Cody D Rickman, Constance Desimone, Courtney N Long, Darin S Wiegers, David P Vanhouten, Dawn M Braswell, Debra J Bennett, Diane Kelley, Douglas Florentino, Dr. Abhijit Raha, PhD, Dr. Mark J Seaton, PhD, Dr. Zhou Chen (nmi), MD PhD, Ekaterina Allen, Ellen P Madigan, Erik W Koester, Erika V Butler, Gary J Hagan, Gary S Hagan, Gene D Arcy, Gunther Bockhoudt, Gunther Boekhoudt, PhD, Hien Albright, Ivis Lnegron Torres, Jee Chung, PhD, Joey V Quitania, John P Mistler, John S Hartford, Jose A Cruz, Jose Acruz Gonzalez, Jose M Cayuela, Jose R Hernandez, Joyce A Rockwell, Julie D Bringger, Justine M Corson, Kara A Scheibner, PhD, Kathleen E Mcafoose, Kathleen R Jones, PhD, Kelvin Cheung, Kenneth G Klobus, Kent A Conforti, Kham Phommachanh, Kristy A Zielny, Laurie B Frazier, LCDR Debra Emerson, Leo B Zadecky, Martha T Olone, Martin J Guardia, Mary Jeanet Mcgarry, Marybet Lopez, Marybet Lopez Negron, Matthew B Casale, Matthew C Watson, Maxwell Van Tassell, PhD, Megan A Haggerty, Michael R Goga, Michelle M Noe, Monique C Lo, Mra Davism, Mra Mcculloughj, Nailing Zhang, Norman Wong, Paraluman S Leonin, Parul M Patel, Patricia A Mcilroy, Paul L Figarole, Jr, Paula A Trost, Philip Kreiter, Prabhu P Raju, Priscilla M Pastrana, Rebecca Rodriguez, Reyes Candau Chacon, PhD, Richard H Penta, Richard Ledwidge (nmi), PhD, Richard W Thornton, Rory K Geyer, Rosa J Motta, Sean R Marcsisin, Seth A Mailhot, Stacey S Degarmo, Stephen D Eich, Susan M Jackson, Susan O Oladeji, Susanne M Richardson, MSc RAC ELS, Tricia S Martinez, Victoria M Daddeo, Walter Lange, Wayne E Seifert, Xiao Hong Chen, Yanming An, PhD, Yumi J Hiramine, Zhihao Qiu (Peter), PhD, Zhong Li, PhD

Victor J Gangi's Documents

Publish Date Document Type Title
April, 2000 EIR Sanofi Chimie - EIR, 2000-05-23
July, 2000 EIR Grunenthal GmbH - EIR, 2000-07-12
January, 2000 FDA 483 Muro Pharmaceutical Inc. - Form 483, 2000-01-31
August, 2000 EIR Labcorp Bedford LLC. - EIR, 2000-08-30
July, 2000 FDA 483 Janssen - Cilag S.p.A. - Form 483, 2000-07-06
April, 2000 EIR Codan Medizinische Gerate Gmbh - EIR, 2000-06-01
September, 2000 EIR Justesa Imagen, S.A.U. - EIR, 2000-10-24
April, 2000 FDA 483 Aventis Pharma - Form 483, 2000-04-14
April, 2000 FDA 483 Response Sanofi Chimie - Form 483R, 2000-05-09
September, 2000 EIR Quimica Sintetica S.A. - EIR, 2000-09-18
September, 2000 FDA 483 Response Justesa Imagen, S.A.U. - Form 483R, 2000-11-21
July, 2000 EIR Janssen - Cilag S.p.A. - EIR, 2005-05-18
September, 2000 FDA 483 Quimica Sintetica S.A. - Form 483, 2000-09-18
September, 2000 FDA 483 Response Quimica Sintetica S.A. - Form 483R, 2000-10-31
July, 2000 FDA 483 Response Janssen - Cilag S.p.A. - Form 483R, 2000-07-31
January, 2000 FDA 483 Response Muro Pharmaceutical Inc. - Form 483R, 2000-02-03

Experience Redica System's NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more